GlassScriptPhysician profile
Mimi M Propst
NPI 1639482912
$798.11
in general payments reported to CMS, 2019-2025
13 companies · $360 in 2025
The $360 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $270 · 2020: $106 · 2024: $61.93 · 2025: $360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $357 · Education: $64.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $356.64 |
| Education | $64.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $322.99 | 2025 | Tremfya, Simponi Aria |
| Pfizer INC. | $208.69 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $61.93 | 2024 | |
| Novo Nordisk INC | $46.01 | 2019-2020 | |
| Daiichi Sankyo INC. | $29.85 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $23.91 | 2020 | |
| Organon LLC | $22.52 | 2025 | Hadlima |
| Novartis Pharmaceuticals Corporation | $17.60 | 2020 | |
| Amgen INC. | $14.77 | 2019 | |
| Exact Sciences Corporation | $14.15 | 2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $12.36 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.22 | 2019 | |
| Supernus Pharmaceuticals, INC. | $11.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mimi Propst listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.